What Labcorp Holdings Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 5 | 21 |
| Total trades | 6 | 150 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 1,338 | 143,966 |
| Disposed | 10,013 | 105,716 |
| Net activity | −8,675 | +38,250 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Anderson Kerrii B | Director | Aug 17 | Open-market sale · S | −3,000 | $318.02 | −$954K | 6,563 |
| Schechter Adam H | President & CEO | Aug 11 | Open-market sale · S | −4,669 | $320.37 | −$1.5M | 102,565 |
| Summy Amy B. | EVP, Chief Marketing Officer | Aug 04 | Open-market sale · S | −924 | $306.74 | −$283K | 6,956 |
| Wilkinson Peter J | SVP, Chief Accounting Officer | Aug 03 | Open-market sale · S | −1,338 | $309.23 | −$414K | 1,770 |
| Wilkinson Peter J | SVP, Chief Accounting Officer | Aug 03 | Exercise / conversion · M | +1,338 | $209.25 | +$280K | 3,108 |
| Wilkinson Peter J | SVP, Chief Accounting Officer | Aug 03 | Open-market sale · S | −82 | $309.22 | −$25.4K | 1,770 |
| Kyle Kathryn W | EVP, Chief Legal Officer | Jul 02 | Open-market sale · S | −92 | $286.19 | −$26.3K | 3,904 |
| Vaughn Bryan T | EVP and President, Diagnostics | Jul 02 | Open-market sale · S | −234 | $286.19 | −$67K | 6,746 |
| Kyle Kathryn W | EVP, Chief Legal Officer | Jul 01 | Withheld — tax / exercise cost · F | −73 | $283.88 | −$20.7K | 3,996 |
| Kyle Kathryn W | EVP, Chief Legal Officer | Jul 01 | Exercise / conversion · M | +256 | — | — | 4,069 |
| Vaughn Bryan T | EVP and President, Diagnostics | Jul 01 | Withheld — tax / exercise cost · F | −93 | $283.88 | −$26.4K | 6,980 |
| Vaughn Bryan T | EVP and President, Diagnostics | Jul 01 | Exercise / conversion · M | +327 | — | — | 7,073 |
| Kyle Kathryn W | EVP, Chief Legal Officer | Jun 08 | Open-market sale · S | −762 | $263.89 | −$201K | 3,813 |
| Schechter Adam H | President & CEO | May 11 | Open-market sale · S | −5,903 | $254.50 | −$1.5M | 107,234 |
| Wilkinson Peter J | SVP, Chief Accounting Officer | Mar 27 | Open-market sale · S | −1,633 | $267.05 | −$436K | 1,852 |
| Meltzer Jonathan C | EVP, Operations | Mar 27 | Open-market sale · S | −839 | $267.05 | −$224K | 3,620 |
| Summy Amy B. | EVP, Chief Marketing Officer | Mar 26 | Withheld — tax / exercise cost · F | −1,836 | $268.38 | −$493K | 7,880 |
| Summy Amy B. | EVP, Chief Marketing Officer | Mar 26 | Grant / award · A | +3,994 | — | — | 9,716 |
| Kyle Kathryn W | EVP, Chief Legal Officer | Mar 26 | Withheld — tax / exercise cost · F | −451 | $268.38 | −$121K | 4,575 |
| Kyle Kathryn W | EVP, Chief Legal Officer | Mar 26 | Grant / award · A | +1,584 | — | — | 5,026 |
Loading...
